Company intelligence / Profile preview

Opportunity Advisors

Doylestown, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Opportunity Advisors is a strategic advisory firm specializing in the life sciences, biotechnology, and pharmaceutical sectors. The firm provides expert guidance on corporate strategy, business development, licensing, and commercialization for emerging and established healthcare companies. They often work with clients to optimize portfolio value, navigate complex regulatory landscapes, and facilitate market access for novel therapeutics. The firm is recognized for its deep industry expertise and its role in supporting high-stakes transactions and partnerships within the global healthcare ecosystem.

Industry: Consulting

Beyond the preview

Go deeper on Opportunity Advisors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Opportunity Advisors.

Explore the full profile